CleanSpark shares to outperform bitcoin in 2025, says H.C. Wainwright
H.C. Wainwright analyst Mike Colonnese says CleanSpark (CLSK) reported solid fiscal Q4 results and reiterated its prior calendar year-end 2024 ...
Janux Therapeutics price target raised to $70 from $63 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Janux Therapeutics (JANX) to $70 from $63 and keeps a Buy ...
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...
bovnews10d
H.C. Wainwright Issues Neutral Rating for Ardelyx Inc (ARDX) Stock
H.C. Wainwright has recently reduced Ardelyx Inc (ARDX) stock to Neutral rating, as announced on November 11, 2024, according to Finviz. Earlier, on July 2, 2024, Piper Sandler had reduced the stock ...
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage ...
Why Purple Biotech (PPBT) Stock Is Getting Hammered
Purple Biotech shares are trading lower by 28% during Tuesday's session. The company announced a $2.8 million offering.
bovnews23h
Hut 8 Corp (HUT) Stock Settles at $28.37: What’s Contributing to This Price Point?
On Friday, Hut 8 Corp (HUT) stock saw a decline, ending the day at $28.37 which represents a decrease of $-0.08 or -0.28% from the prior close of $28.45. The stock opened at $28.45 and touched a low ...
ETF Daily News2d
electroCore, Inc. Enters into At The Market Offering Agreement with H.C. Wainwright & Co., LLC
The Company clarified that they are not obligated to sell any Shares under this agreement. H.C. Wainwright & Co., LLC will act to sell the Shares based on electroCore’s instructions and within the ...
Investing4d
H.C. Wainwright reiterates Neutral on Agenus stock, focus on bot/bal in colorectal cancer
On Friday, H.C. Wainwright maintained a Neutral rating and a $7.00 price target on Agenus Inc . (NASDAQ:AGEN), a biotechnology company currently valued at approximately $82 million. According to ...
Investing4d
H.C. Wainwright reiterates Buy on IceCure Medical stock, FDA decision on ProSense expected soon
as recommended by H.C. Wainwright. According to InvestingPro analysis, the stock appears undervalued at its current trading level. The reaffirmation came after IceCure Medical announced its third ...
Nasdaq4d
Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares following the Q3 report. The business stalled until new funding ...
Nasdaq4d
CollPlant initial breast implant data ‘encouraging,’ says H.C. Wainwright
H.C. Wainwright maintains a Buy rating and 12-month price target of $11 on CollPlant (CLGN) shares after the company reported Q3 results and provided a corporate update on November 27. The firm ...